# Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.

> **NCT00430300** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 87 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** UK-432,097
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00430300
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00430300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00430300, "Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00430300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*